Private insurance companies say U.S. patients aren't paying the true cost of expensive medications such as Wegovy and Zepbound, which can easily cost upwards of $1,000. Wegovy, the weight-loss medication made by Novo Nordisk, is listed at $1,349 in the U.S. but sells for a fraction of that in Europe. In the United Kingdom, it costs $92, according to evidence provided…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Sec approves first 24-hour US exchange
Choosing a health insurance plan Choosing a health insurance plan
Advisor News
- Millennials seek trusted financial advice as they build and inherit wealth
- NAIFA: Financial professionals are essential to the success of Trump Accounts
- Changes, personalization impacting retirement plans for 2026
- Study asks: How do different generations approach retirement?
- LTC: A critical component of retirement planning
More Advisor NewsAnnuity News
- Symetra Enhances Fixed Indexed Annuities, Introduces New Franklin Large Cap Value 15% ER Index
- Ancient Financial Launches as a Strategic Asset Management and Reinsurance Holding Company, Announces Agreement to Acquire F&G Life Re Ltd.
- FIAs are growing as the primary retirement planning tool
- Edward Wilson Joins SEDA, Bringing Deep Expertise in Risk Management, Derivatives Trading and Institutional Prime Brokerage
- Trademark Application for “INSPIRING YOUR FINANCIAL FUTURE” Filed by Great-West Life & Annuity Insurance Company: Great-West Life & Annuity Insurance Company
More Annuity NewsHealth/Employee Benefits News
- Rep. Howell, Sen. Watson propose health insurance protection legislation
- Braden Draggoo Named New York Life’s 2025 Council President
- Genworth Financial taking the offensive after years of LTCi rate struggles
- Ambler Brook Announces Strategic Growth Investment in Claimify
- Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan
More Health/Employee Benefits NewsLife Insurance News